ClinicalTrials.Veeva

Menu

Effect of Consuming a Combination of Probiotic Strains and a Combination of Plant Extracts and a Probiotic Strain on the Production and Nutritional Composition of Breast Milk

B

Biosearch Life

Status

Completed

Conditions

Breast Milk Expression

Treatments

Dietary Supplement: Prob-milk
Dietary Supplement: Voluntas-Prob
Dietary Supplement: Placebo

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

The objective of this trial is to evaluate the effect of the consumption of a combination of probiotic strains (Prob-milk) and of a combination of plant extracts plus an inactivated probiotic strain (VoluntasProb) on the production volume and the nutritional composition and the microbiota. of breast milk in lactating women.

Full description

Previous studies have shown the galactogogue effect of fenugreek, fennel, and milk thistle. However, to date no study has considered the evaluation of all three extracts. Additionally, certain probiotic strains of Lactobacillus and Bifidobacterium also appear to increase milk production in animal studies.

The objective of this trial is to evaluate the effect of the consumption of a combination of probiotic strains (Prob-milk) and of a combination of plant extracts plus an inactivated probiotic strain (VoluntasProb) on the production volume and the nutritional composition and the microbiota. of breast milk in lactating women. This is a preliminary study whose purpose is to gather information for future studies.

Enrollment

58 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Lactating women between 18 and 45 years old, who have given birth to a healthy baby at term (born between 37 and 42 weeks).
  2. Who have the perception of having little volume of milk or a nutritional composition of milk that is not adequate for their baby
  3. That they are between week 2 and week 6 of breastfeeding, and that at the time of beginning the study they are not supplementing with formula milk the feeding of their baby.
  4. That they have the firm intention of breastfeeding for 28 more days.
  5. Women who agree to participate and have read, understood and signed the informed consent

Exclusion criteria

  1. Suffering from any disease that may hinder or prevent breastfeeding
  2. Being currently consuming or having consumed in the two weeks prior to the study a probiotic or a supplement with plant extracts.
  3. Being consuming any drug that can alter the volume or composition of breast milk.
  4. Have an allergy to any antibiotics or peanuts
  5. Have an allergy to any of the components of the products under study

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

58 participants in 3 patient groups, including a placebo group

Control group
Placebo Comparator group
Description:
Volunteers will take 6 capsules per day for 28 days a capsule containing maltodextrin.
Treatment:
Dietary Supplement: Placebo
Prob-milk
Experimental group
Description:
Volunteers will take 6 capsules per day for 28 days a capsule containing the probiotics combination.
Treatment:
Dietary Supplement: Prob-milk
Voluntas-Prob
Experimental group
Description:
Volunteers will take 6 capsules per day for 28 days a capsule containing the combination of plant extracts and the inactivated probiotic strain
Treatment:
Dietary Supplement: Voluntas-Prob

Trial contacts and locations

1

Loading...

Central trial contact

Ruth Blanco Rojo, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems